HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 127182,
"next": null,
"previous": "https://api-test.medunigraz.at/v1/research/search/publication/?format=api&limit=20&offset=127160",
"results": [
{
"text": "\n182407\nGlobal Retinoblastoma Presentation and Analysis by National Income Level.\n\nFabian, ID\n\nAbdallah, E\n\nAbdullahi, SU\n\nAbdulqader, RA\n\nBoubacar, SA\n\nAdemola-Popoola, DS\n\nAdio, A\n\nAfshar, AR\n\nAggarwal, P\n\nAghaji, AE\n\nAhmad, A\n\nAkib, MNR\n\nAl Harby, L\n\nAl Ani, MH\n\nAlakbarova, A\n\nPortabella, SA\n\nAl-Badri, SAF\n\nAlcasabas, APA\n\nAl-Dahmash, SA\n\nAlejos, A\n\nAlemany-Rubio, E\n\nBio, AIA\n\nCarreras, YA\n\nAl-Haddad, C\n\nAl-Hussaini, HHY\n\nAli, AM\n\nAlia, DB\n\nAl-Jadiry, MF\n\nAl-Jumaly, U\n\nAlkatan, HM\n\nAll-Eriksson, C\n\nAl-Mafrachi, AARM\n\nAlmeida, AA\n\nAlsawidi, KM\n\nAl-Shaheen, AASM\n\nAl-Shammary, EH\n\nAmiruddin, PO\n\nAntonino, R\n\nAstbury, NJ\n\nAtalay, HT\n\nAtchaneeyasakul, LO\n\nAtsiaya, R\n\nAttaseth, T\n\nAung, TH\n\nAyala, S\n\nBaizakova, B\n\nBalaguer, J\n\nBalayeva, R\n\nBalwierz, W\n\nBarranco, H\n\nBascaran, C\n\nPopovic, MB\n\nBenavides, R\n\nBenmiloud, S\n\nGuebessi, NB\n\nBerete, RC\n\nBerry, JL\n\nBhaduri, A\n\nBhat, S\n\nBiddulph, SJ\n\nBiewald, EM\n\nBobrova, N\n\nBoehme, M\n\nBoldt, HC\n\nBonanomi, MTBC\n\nBornfeld, N\n\nBouda, GC\n\nBouguila, H\n\nBoumedane, A\n\nBrennan, RC\n\nBrichard, BG\n\nBuaboonnam, J\n\nCalderon-Sotelo, P\n\nJara, DAC\n\nCamuglia, JE\n\nCano, MR\n\nCapra, M\n\nCassoux, N\n\nCastela, G\n\nCastillo, L\n\nCatala-Mora, J\n\nChantada, GL\n\nChaudhry, S\n\nChaugule, SS\n\nChauhan, A\n\nChawla, B\n\nChernodrinska, VS\n\nChiwanga, FS\n\nChuluunbat, T\n\nCieslik, K\n\nCockcroft, RL\n\nComsa, C\n\nCorrea, ZM\n\nLlano, MGC\n\nCorson, TW\n\nCowan-Lyn, KE\n\nCsoka, M\n\nCui, XH\n\nDa Gama, IV\n\nDangboon, W\n\nDas, A\n\nDas, S\n\nDavanzo, JM\n\nDavidson, A\n\nDe Potter, P\n\nDelgado, KQ\n\nDemirci, H\n\nDesjardins, L\n\nCoronado, RYD\n\nDimaras, H\n\nDodgshun, AJ\n\nDonaldson, C\n\nMacedo, CRD\n\nDragomir, MD\n\nDu, Y\n\nDu Bruyn, M\n\nEdison, KS\n\nSutyawan, IWE\n\nEl Kettani, A\n\nElbahi, AM\n\nElder, JE\n\nElgalaly, D\n\nElhaddad, AM\n\nElhassan, MMA\n\nElzembely, MM\n\nEssuman, VA\n\nEvina, TGA\n\nFadoo, Z\n\nFandino, AC\n\nFaranoush, M\n\nFasina, O\n\nFernandez, DDPG\n\nFernandez-Teijeiro, A\n\nFoster, A\n\nFrenkel, S\n\nFu, LD\n\nFuentes-Alabi, SL\n\nGallie, BL\n\nGandiwa, M\n\nGarcia, JL\n\nAldana, DG\n\nGassant, PY\n\nGeel, JA\n\nGhassemi, F\n\nGiron, AV\n\nGizachew, Z\n\nGoenz, MA\n\nGold, AS\n\nGoldberg-Lavid, M\n\nGole, GA\n\nGomel, N\n\nGonzalez, E\n\nPerez, GG\n\nGonzalez-Rodriguez, L\n\nPacheco, HNG\n\nGraells, J\n\nGreen, L\n\nGregersen, PA\n\nGrigorovski, NDAK\n\nGuedenon, KM\n\nGunasekera, DS\n\nGunduz, AK\n\nGupta, H\n\nGupta, S\n\nHadjistilianou, T\n\nHamel, P\n\nHamid, SA\n\nHamzah, N\n\nHansen, ED\n\nHarbour, JW\n\nHartnett, ME\n\nHasanreisoglu, M\n\nHassan, S\n\nHassan, S\n\nHederova, S\n\nHernandez, J\n\nHernandez, LMC\n\nHessissen, L\n\nHordofa, DF\n\nHuang, LC\n\nHubbard, GB\n\nHummlen, M\n\nHusakova, K\n\nAl-Janabi, ANH\n\nIda, R\n\nIlic, VR\n\nJairaj, V\n\nJeeva, I\n\nJenkinson, H\n\nJi, XD\n\nJo, DH\n\nJohnson, KP\n\nJohnson, WJ\n\nJones, MM\n\nKabesha, TBA\n\nKabore, RL\n\nKaliki, S\n\nKalinaki, A\n\nKantar, M\n\nKao, LY\n\nKardava, T\n\nKebudi, R\n\nKepak, T\n\nKeren-Froim, N\n\nKhan, ZJ\n\nKhaqan, HA\n\nKhauv, P\n\nKheir, WJ\n\nKhetan, V\n\nKhodabande, A\n\nKhotenashvili, Z\n\nKim, JW\n\nKim, JH\n\nKiratli, H\n\nKivela, TT\n\nKlett, A\n\nPalet, JEKK\n\nKrivaitiene, D\n\nKruger, M\n\nKulvichit, K\n\nKuntorini, MW\n\nKyara, A\n\nLachmann, ES\n\nLam, CPS\n\nLam, GC\n\nLarson, SA\n\nLatinovic, S\n\nLaurenti, KD\n\nLe, BHA\n\nLecuona, K\n\nLeverant, AA\n\nLi, CR\n\nLimbu, B\n\nLong, QB\n\nLopez, JP\n\nLukamba, RM\n\nLumbroso, L\n\nLuna-Fineman, S\n\nLutfi, D\n\nLysytsia, L\n\nMagrath, GN\n\nMahajan, A\n\nMajeed, AR\n\nMaka, E\n\nMakan, M\n\nMakimbetov, EK\n\nManda, C\n\nBegue, NM\n\nMason, L\n\nMason, JO\n\nMatende, IO\n\nMaterin, M\n\nMattosinho, CCDS\n\nMatua, M\n\nMayet, I\n\nMbumba, FB\n\nMcKenzie, JD\n\nMedina-Sanson, A\n\nMehrvar, A\n\nMengesha, AA\n\nMenon, V\n\nMercado, GJVD\n\nMets, MB\n\nMidena, E\n\nMishra, DKC\n\nMndeme, FG\n\nMohamedani, AA\n\nMohammad, MT\n\nMoll, AC\n\nMontero, MM\n\nMorales, RA\n\nMoreira, C\n\nMruthyunjaya, P\n\nM\n\nBeiträge in Fachzeitschriften\nISI:000536236800012\nNone\n10.1001/jamaoncol.2019.6716\nNone\nThis cross-sectional analysis reports the retinoblastoma stage at diagnosis across the world during a single year, investigates associations between clinical variables and national income level, and investigates risk factors for advanced disease at diagnosis. Key PointsQuestionIs the income level of a country of residence associated with the clinical stage of presentation of patients with retinoblastoma? FindingsIn this cross-sectional analysis that included 4351 patients with newly diagnosed retinoblastoma, approximately half of all new retinoblastoma cases worldwide in 2017, 49.1% of patients from low-income countries had extraocular tumor at time of diagnosis compared with 1.5% of patients from high-income countries. MeaningThe clinical stage of presentation of retinoblastoma, which has a major influence on survival, significantly differs among patients from low-income and high-income countries, which may warrant intervention on national and international levels. ImportanceEarly diagnosis of retinoblastoma, the most common intraocular cancer, can save both a child's life and vision. However, anecdotal evidence suggests that many children across the world are diagnosed late. To our knowledge, the clinical presentation of retinoblastoma has never been assessed on a global scale. ObjectivesTo report the retinoblastoma stage at diagnosis in patients across the world during a single year, to investigate associations between clinical variables and national income level, and to investigate risk factors for advanced disease at diagnosis. Design, Setting, and ParticipantsA total of 278 retinoblastoma treatment centers were recruited from June 2017 through December 2018 to participate in a cross-sectional analysis of treatment-naive patients with retinoblastoma who were diagnosed in 2017. Main Outcomes and MeasuresAge at presentation, proportion of familial history of retinoblastoma, and tumor stage and metastasis. ResultsThe cohort included 4351 new patients from 153 countries; the median age at diagnosis was 30.5 (interquartile range, 18.3-45.9) months, and 1976 patients (45.4%) were female. Most patients (n=3685 [84.7%]) were from low- and middle-income countries (LMICs). Globally, the most common indication for referral was leukocoria (n=2638 [62.8%]), followed by strabismus (n=429 [10.2%]) and proptosis (n=309 [7.4%]). Patients from high-income countries (HICs) were diagnosed at a median age of 14.1 months, with 656 of 666 (98.5%) patients having intraocular retinoblastoma and 2 (0.3%) having metastasis. Patients from low-income countries were diagnosed at a median age of 30.5 months, with 256 of 521 (49.1%) having extraocular retinoblastoma and 94 of 498 (18.9%) having metastasis. Lower national income level was associated with older presentation age, higher proportion of locally advanced disease and distant metastasis, and smaller proportion of familial history of retinoblastoma. Advanced disease at diagnosis was more common in LMICs even after adjusting for age (odds ratio for low-income countries vs upper-middle-income countries and HICs, 17.92 [95% CI, 12.94-24.80], and for lower-middle-income countries vs upper-middle-income countries and HICs, 5.74 [95% CI, 4.30-7.68]). Conclusions and RelevanceThis study is estimated to have included more than half of all new retinoblastoma cases worldwide in 2017. Children from LMICs, where the main global retinoblastoma burden lies, presented at an older age with more advanced disease and demonstrated a smaller proportion of familial history of retinoblastoma, likely because many do not reach a childbearing age. Given that retinoblastoma is curable, these data are concerning and mandate intervention at national and international levels. Further studies are needed to investigate factors, other than age at presentation, that may be associated with advanced disease in LMICs.\n\nRitter-Sovinz, Petra\n\n\n"
},
{
"text": "\n152918\n32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.\n\nLangsteger, W\n\nRezaee, A\n\nLoidl, W\n\nGeinitz, HS\n\nFitz, F\n\nSteinmair, M\n\nBroinger, G\n\nPallwien-Prettner, L\n\nBeheshti, M\n\nImamovic, L\n\nBeheshti, M\n\nRendl, G\n\nHackl, D\n\nTsybrovsky, O\n\nSteinmair, M\n\nEmmanuel, K\n\nMoinfar, F\n\nPirich, C\n\nLangsteger, W\n\nBytyqi, A\n\nKaranikas, G\n\nMayerhöfer, M\n\nKoperek, O\n\nNiederle, B\n\nHartenbach, M\n\nBeyer, T\n\nHerrmann, K\n\nCzernin, J\n\nRausch, I\n\nRust, P\n\nDiFranco, MD\n\nLassen, M\n\nStadlbauer, A\n\nMayerhöfer, ME\n\nHartenbach, M\n\nHacker, M\n\nBeyer, T\n\nBinzel, K\n\nMagnussen, R\n\nWei, W\n\nKnopp, MU\n\nFlanigan, DC\n\nKaeding, C\n\nKnopp, MV\n\nLeisser, A\n\nNejabat, M\n\nHartenbach, M\n\nKramer, G\n\nKrainer, M\n\nHacker, M\n\nHaug, A\n\nLehnert, W\n\nSchmidt, K\n\nKimiaei, S\n\nBronzel, M\n\nKluge, A\n\nWright, CL\n\nBinzel, K\n\nZhang, J\n\nWuthrick, E\n\nManiawski, P\n\nKnopp, MV\n\nBlaickner, M\n\nRados, E\n\nHuber, A\n\nDulovits, M\n\nKulkarni, H\n\nWiessalla, S\n\nSchuchardt, C\n\nBaum, RP\n\nKnäusl, B\n\nGeorg, D\n\nBauer, M\n\nWulkersdorfer, B\n\nWadsak, W\n\nPhilippe, C\n\nHaslacher, H\n\nZeitlinger, M\n\nLanger, O\n\nBauer, M\n\nFeldmann, M\n\nKarch, R\n\nWadsak, W\n\nZeitlinger, M\n\nKoepp, MJ\n\nAsselin, MC\n\nPataraia, E\n\nLanger, O\n\nZeilinger, M\n\nPhilippe, C\n\nDumanic, M\n\nPichler, F\n\nPilz, J\n\nHacker, M\n\nWadsak, W\n\nMitterhauser, M\n\nNics, L\n\nSteiner, B\n\nHacker, M\n\nMitterhauser, M\n\nWadsak, W\n\nTraxl, A\n\nWanek, T\n\nKryeziu, K\n\nMairinger, S\n\nStanek, J\n\nBerger, W\n\nKuntner, C\n\nLanger, O\n\nMairinger, S\n\nWanek, T\n\nTraxl, A\n\nKrohn, M\n\nStanek, J\n\nFilip, T\n\nSauberer, M\n\nKuntner, C\n\nPahnke, J\n\nLanger, O\n\nSvatunek, D\n\nDenk, C\n\nWilkovitsch, M\n\nWanek, T\n\nFilip, T\n\nKuntner-Hannes, C\n\nFröhlich, J\n\nMikula, H\n\nDenk, C\n\nSvatunek, D\n\nWanek, T\n\nMairinger, S\n\nStanek, J\n\nFilip, T\n\nFröhlich, J\n\nMikula, H\n\nKuntner-Hannes, C\n\nBalber, T\n\nSinger, J\n\nFazekas, J\n\nRami-Mark, C\n\nBerroterán-Infante, N\n\nJensen-Jarolim, E\n\nWadsak, W\n\nHacker, M\n\nViernstein, H\n\nMitterhauser, M\n\nDenk, C\n\nSvatunek, D\n\nSohr, B\n\nMikula, H\n\nFröhlich, J\n\nWanek, T\n\nKuntner-Hannes, C\n\nFilip, T\n\nPfaff, S\n\nPhilippe, C\n\nMitterhauser, M\n\nHartenbach, M\n\nHacker, M\n\nWadsak, W\n\nWanek, T\n\nHalilbasic, E\n\nVisentin, M\n\nMairinger, S\n\nStieger, B\n\nKuntner, C\n\nTrauner, M\n\nLanger, O\n\nLam, P\n\nAistleitner, M\n\nEichinger, R\n\nArtner, C\n\nEidherr, H\n\nVraka, C\n\nHaug, A\n\nMitterhauser, M\n\nNics, L\n\nHartenbach, M\n\nHacker, M\n\nWadsak, W\n\nKvaternik, H\n\nMüller, R\n\nHausberger, D\n\nZink, C\n\nAigner, RM\n\nCossío, U\n\nAsensio, M\n\nMontes, A\n\nAkhtar, S\n\nTe Welscher, Y\n\nvan Nostrum, R\n\nGómez-Vallejo, V\n\nLlop, J\n\nVandeVyver, F\n\nBarclay, T\n\nLippens, N\n\nTroch, M\n\nHehenwarter, L\n\nEgger, B\n\nHolzmannhofer, J\n\nRodrigues-Radischat, M\n\nPirich, C\n\nPötsch, N\n\nRausch, I\n\nWilhelm, D\n\nWeber, M\n\nFurtner, J\n\nKaranikas, G\n\nWöhrer, A\n\nMitterhauser, M\n\nHacker, M\n\nTraub-Weidinger, T\n\nCassou-Mounat, T\n\nBalogova, S\n\nNataf, V\n\nCalzada, M\n\nHuchet, V\n\nKerrou, K\n\nDevaux, JY\n\nMohty, M\n\nGarderet, L\n\nTalbot, JN\n\nStanzel, S\n\nPregartner, G\n\nSchwarz, T\n\nBjelic-Radisic, V\n\nLiegl-Atzwanger, B\n\nAigner, R\n\nStanzel, S\n\nQuehenberger, F\n\nAigner, RM\n\nMarković, AK\n\nJanković, M\n\nJerković, VM\n\nPaskaš, M\n\nPupić, G\n\nDžodić, R\n\nPopović, D\n\nFornito, MC\n\nFamiliari, D\n\nKoranda, P\n\nPolzerová, H\n\nMetelková, I\n\nHenzlová, L\n\nFormánek, R\n\nBuriánková, E\n\nKamínek, M\n\nThomson, WH\n\nLewis, C\n\nThomson, WH\n\nO'Brien, J\n\nJames, G\n\nNotghi, A\n\nHuber, H\n\nStelzmüller, I\n\nWunn, R\n\nMandl, M\n\nFellner, F\n\nLamprecht, B\n\nGabriel, M\n\nFornito, MC\n\nLeonardi, G\n\nThomson, WH\n\nO'Brien, J\n\nJames, G\n\nHudzietzová, J\n\nSabol, J\n\nFülöp, M\n\nPublizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen\nNone\n27090254.0\n10.1186/s13550-016-0168-9\nPMC4835428\nA1 68Ga-PSMA PET/CT in staging and restaging of Prostate Cancer Patients: comparative study with 18F-Choline PET/CTW Langsteger, A Rezaee, W Loidl, HS Geinitz, F Fitz, M Steinmair, G Broinger, L Pallwien-Prettner, M BeheshtiA2 F18 Choline PET - CT: an accurate diagnostic tool for the detection of parathyroid adenoma?L Imamovic, M Beheshti, G Rendl, D Hackl, O Tsybrovsky, M Steinmair, K Emmanuel, F Moinfar, C Pirich, W LangstegerA3 [18F]Fluoro-DOPA-PET/CT in the primary diagnosis of medullary thyroid carcinomaA Bytyqi, G Karanikas, M Mayerhöfer, O Koperek, B Niederle, M HartenbachA4 Variations of clinical PET/MR operations: An international survey on the clinical utilization of PET/MRIT Beyer, K Herrmann, J CzerninA5 Standard Dixon-based attenuation correction in combined PET/MRI: Reproducibility and the possibility of Lean body mass estimationI Rausch, P Rust, MD DiFranco, M Lassen, A Stadlbauer, ME Mayerhöfer, M Hartenbach, M Hacker, T BeyerA6 High resolution digital FDG PET/MRI imaging for assessment of ACL graft viabilityK Binzel, R Magnussen, W Wei, MU Knopp, DC Flanigan, C Kaeding, MV KnoppA7 Using pre-existing hematotoxicity as predictor for severe side effects and number of treatment cycles of Xofigo therapyA Leisser, M Nejabat, M Hartenbach, G Kramer, M Krainer, M Hacker, A HaugA8 QDOSE - comprehensive software solution for internal dose assessmentWencke Lehnert, Karl Schmidt, Sharok Kimiaei, Marcus Bronzel, Andreas KlugeA9 Clinical impact of Time-of-Flight on next-generation digital PET imaging of Yttrium-90 radioactivity following liver radioembolizationCL Wright, K Binzel, J Zhang, Evan Wuthrick, Piotr Maniawski, MV KnoppA10 Snakes in patients! Lessons learned from programming active contours for automated organ segmentationM Blaickner, E Rados, A Huber, M Dulovits, H Kulkarni, S Wiessalla, C Schuchardt, RP Baum, B Knäusl, D GeorgA11 Influence of a genetic polymorphism on brain uptake of the dual ABCB1/ABCG2 substrate [11C]tariquidarM Bauer, B Wulkersdorfer, W Wadsak, C Philippe, H Haslacher, M Zeitlinger, O LangerA12 Outcome prediction of temporal lobe epilepsy surgery from P-glycoprotein activity. Pooled analysis of (R)-[11C]-verapamil PET data from two European centresM Bauer, M Feldmann, R Karch, W Wadsak, M Zeitlinger, MJ Koepp, M-C Asselin, E Pataraia, O LangerA13 In-vitro and in-vivo characterization of [18F]FE@SNAP and derivatives for the visualization of the melanin concentrating hormone receptor 1M Zeilinger, C Philippe, M Dumanic, F Pichler, J Pilz, M Hacker, W Wadsak, M MitterhauserA14 Reducing time in quality control leads to higher specific radioactivity of short-lived radiotracersL Nics, B Steiner, M Hacker, M Mitterhauser, W WadsakA15 In vitro 11C-erlotinib binding experiments in cancer cell lines with epidermal growth factor receptor mutationsA Traxl, Thomas Wanek, Kushtrim Kryeziu, Severin Mairinger, Johann Stanek, Walter Berger, Claudia Kuntner, Oliver LangerA16 7-[11C]methyl-6-bromopurine, a PET tracer to measure brain Mrp1 function: radiosynthesis and first PET evaluation in miceS Mairinger, T Wanek, A Traxl, M Krohn, J Stanek, T Filip, M Sauberer, C Kuntner, J Pahnke, O LangerA17 18F labeled azidoglucose derivatives as "click" agents for pretargeted PET imagingD Svatunek, C Denk, M Wilkovitsch, T Wanek, T Filip, C Kuntner-Hannes, J Fröhlich, H MikulaA18 Bioorthogonal tools for PET imaging: development of radiolabeled 1, , , -TetrazinesC Denk, D Svatunek, T Wanek, S Mairinger, J Stanek, T Filip, J Fröhlich, H Mikula, C Kuntner-HannesA19 Preclinical evaluation of [18F]FE@SUPPY- a new PET-tracer for oncologyT Balber, J Singer, J Fazekas, C Rami-Mark, N Berroterán-Infante, E Jensen-Jarolim, W Wadsak, M Hacker, H Viernstein, M MitterhauserA20 Investigation of Small [18F]-Fluoroalkylazides for Rapid Radiolabeling and In Vivo Click ChemistryC Denk, D Svatunek, B Sohr, H Mikula, J Fröhlich, T Wanek, C Kuntner-Hannes, T FilipA21 Microfluidic 68Ga-radiolabeling of PSMA-HBED-CC using a flow-through reactorS Pfaff, C Philippe, M Mitterhauser, M Hartenbach, M Hacker, W WadsakA22 Influence of 24-nor-ursodeoxycholic acid on hepatic disposition of [18F]ciprofloxacin measured with positron emission tomographyT Wanek, E Halilbasic, M Visentin, S Mairinger, B Stieger, C Kuntner, M Trauner, O LangerA23 Automated 18F-flumazenil production using chemically resistant disposable cassettesP Lam, M Aistleitner, R Eichinger, C ArtnerA24 Similarities and differences in the synthesis and quality control of 177Lu-DOTA-TATE, 177Lu -HA-DOTA-TATE and 177Lu-DOTA-PSMA (PSMA-617)H Eidherr, C Vraka, A Haug, M Mitterhauser, L Nics, M Hartenbach, M Hacker, W WadsakA25 68Ga- and 177Lu-labelling of PSMA-617H Kvaternik, R Müller, D Hausberger, C Zink, RM AignerA26 Radiolabelling of liposomes with 67Ga and biodistribution studies after administration by an aerosol inhalation systemU Cossío, M Asensio, A Montes, S Akhtar, Y te Welscher, R van Nostrum, V Gómez-Vallejo, J LlopA27 Fully automated quantification of DaTscan SPECT: Integration of age and gender differencesF VandeVyver, T Barclay, N Lippens, M TrochA28 Lesion-to-background ratio in co-registered 18F-FET PET/MR imaging - is it a valuable tool to differentiate between low grade and high grade brain tumor?L Hehenwarter, B Egger, J Holzmannhofer, M Rodrigues-Radischat, C PirichA29 [11C]-methionine PET in gliomas - a retrospective data analysis of 166 patientsN Pötsch, I Rausch, D Wilhelm, M Weber, J Furtner, G Karanikas, A Wöhrer, M Mitterhauser, M Hacker, T Traub-WeidingerA30 18F-Fluorocholine versus 18F-Fluorodeoxyglucose for PET/CT imaging in patients with relapsed or progressive multiple myeloma: a pilot studyT Cassou-Mounat, S Balogova, V Nataf, M Calzada, V Huchet, K Kerrou, J-Y Devaux, M Mohty, L Garderet, J-N TalbotA31 Prognostic benefit of additional SPECT/CT in sentinel lymph node mapping of breast cancer patientsS Stanzel, G Pregartner, T Schwarz, V Bjelic-Radisic, B Liegl-Atzwanger, R AignerA32 Evaluation of diagnostic value of TOF-18F-FDG PET/CT in patients with suspected pancreatic cancerS Stanzel, F Quehenberger, RM AignerA33 New quantification method for diagnosis of primary hyperpatahyroidism lesions and differential diagnosis vs thyropid nodular disease in dynamic scintigraphyA Koljević Marković, Milica Janković, V Miler Jerković, M Paskaš, G Pupić, R Džodić, D PopovićA34 A rare case of diffuse pancreatic involvement in patient with merkel cell carcinoma detected by 18F-FDGMC Fornito, D FamiliariA35 TSH-stimulated 18F-FDG PET/CT in the diagnosis of recurrent/metastatic radioiodine-negative differentiated thyroid carcinomas in patients with various thyroglobuline levelsP Koranda, H Polzerová, I Metelková, L Henzlová, R Formánek, E Buriánková, M KamínekA36 Breast Dose from lactation following I131 treatmentWH Thomson, C LewisA37 A new concept for performing SeHCAT studies with the gamma cameraWH Thomson, J O'Brien, G James, A NotghiA38 Whole body F-18-FDG-PET and tuberculosis: sensitivity compared to x-ray-CTH Huber, I Stelzmüller, R Wunn, M Mandl, F Fellner, B Lamprecht, M GabrielA39 Emerging role 18F-FDG PET-CT in the diagnosis and follow-up of the infection in heartware ventricular assist system (HVAD)MC Fornito, G LeonardiA40 Validation of Poisson resampling softwareWH Thomson, J O'Brien, G JamesA41 Protection of PET nuclear medicine personnel: problems in satisfying dose limit requirementsJ Hudzietzová, J Sabol, M Fülöp.\n\nAigner, Reingard\n\nBjelic-Radisic, Vesna\n\nPregartner, Gudrun\n\nQuehenberger, Franz\n\nStanzel, Susanne\n\n\n"
}
]
}